• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明质酸钠凝胶20:对其治疗骨关节炎关节疼痛的安全性和有效性的综述

Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis.

作者信息

Migliore A, Giovannangeli F, Granata M, Laganà B

机构信息

UOS of Rheumatology, S.Pietro FBF Hospital, Rome, Italy.

出版信息

Clin Med Insights Arthritis Musculoskelet Disord. 2010 Sep 20;3:55-68.

PMID:21151854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2998981/
Abstract

BACKGROUND

Osteoarthritis (OA) is a chronic degenerative joint disease that is a clinically and economically important disease. The increased prevalence of OA with aging, coupled to the demographics of aging populations, make OA a high priority health care problem. Viscosupplementation (VS) is a well-established treatment option in knee OA that is included in the professional guidelines for treatment of this joint disease, and could potentially provide a useful alternative in treating such patients with painful OA. Theoretically VS is an approach that should apply to all synovial joints.

OBJECTIVES

The aim of this review is to assess the efficacy and safety of viscosupplementation with Hylan GF-20 (Synvisc(®)) in the management of joint pain in osteoarthritis.

METHODS

THE FOLLOWING DATABASES WERE SEARCHED: Medline, Database of Abstract on Reviews and Effectiveness, Cochrane Database of Systematic Reviews. Furthermore, the lists of references of retrieved publications were manually checked for additional references. The search terms Review, Viscosupplementation, Osteoarthritis, Hyaluronic acid, Hyaluronan, Sodium Hyaluronate, Hylan GF-20, Synvisc, intra-articular injection were used to identify all studies relating to the use of Synvisc(®) viscosupplementation therapy in OA.

RESULTS

Hylan GF-20 is a safe and effective treatment for decreasing pain and improving function in patients suffering from knee and hip OA but new evidences are emerging for its use in other joints.

摘要

背景

骨关节炎(OA)是一种慢性退行性关节疾病,在临床和经济方面都是重要疾病。OA的患病率随年龄增长而增加,再加上老龄化人口的统计数据,使得OA成为一个高度优先的医疗保健问题。关节腔注射透明质酸钠(VS)是膝关节OA中一种成熟的治疗选择,已被纳入该关节疾病的专业治疗指南,并且可能为治疗此类疼痛性OA患者提供一种有用的替代方法。理论上,VS是一种应适用于所有滑膜关节的方法。

目的

本综述的目的是评估关节腔注射透明质酸钠(Hylan GF-20,商品名施沛特(Synvisc®))治疗骨关节炎关节疼痛的疗效和安全性。

方法

检索了以下数据库:医学文献数据库、循证医学数据库、Cochrane系统评价数据库。此外,还手动检查了检索到的出版物的参考文献列表以获取其他参考文献。使用检索词“综述”“关节腔注射透明质酸钠”“骨关节炎”“透明质酸”“玻璃酸”“透明质酸钠”“Hylan GF-20”“施沛特”“关节内注射”来识别所有与施沛特(Synvisc®)关节腔注射补充疗法在OA中的应用相关的研究。

结果

Hylan GF-20是一种安全有效的治疗方法,可减轻膝关节和髋关节OA患者的疼痛并改善其功能,但在其他关节使用的新证据也在不断涌现。

相似文献

1
Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis.透明质酸钠凝胶20:对其治疗骨关节炎关节疼痛的安全性和有效性的综述
Clin Med Insights Arthritis Musculoskelet Disord. 2010 Sep 20;3:55-68.
2
Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.使用透明质酸钠凝胶20进行膝关节腔内粘弹性补充治疗骨关节炎:一项循证分析。
Ont Health Technol Assess Ser. 2005;5(10):1-66. Epub 2005 Jun 1.
3
What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature.髋关节骨关节炎患者治疗中使用粘弹性补充疗法的证据是什么?文献系统评价。
Arch Orthop Trauma Surg. 2008 Aug;128(8):815-23. doi: 10.1007/s00402-007-0447-z. Epub 2007 Sep 15.
4
A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee.膝关节骨关节炎粘弹性补充疗法的综合综述
Orthop Rev (Pavia). 2021 Jul 10;13(2):25549. doi: 10.52965/001c.25549. eCollection 2021.
5
Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.超声引导下关节内注射透明质酸钠凝胶(施沛特)治疗有症状的髋关节骨关节炎的开放性初步研究。
Clin Rheumatol. 2005 Jun;24(3):285-9. doi: 10.1007/s10067-004-1009-1. Epub 2004 Dec 9.
6
Viscosupplementation for the treatment of osteoarthritis of the knee.用于治疗膝关节骨关节炎的粘弹性补充疗法。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD005321. doi: 10.1002/14651858.CD005321.
7
Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis.透明质酸钠G-F 20用于膝和髋骨关节炎的粘弹性补充治疗的成本效益及预算影响分析
Clinicoecon Outcomes Res. 2019 Jul 22;11:453-464. doi: 10.2147/CEOR.S194669. eCollection 2019.
8
The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.透明质酸钠(施沛特)关节腔注射补充疗法在膝关节骨关节炎治疗中的作用:一项加拿大多中心试验,比较单独使用透明质酸钠、透明质酸钠与非甾体抗炎药联合使用以及单独使用非甾体抗炎药的疗效。
Osteoarthritis Cartilage. 1995 Dec;3(4):213-25. doi: 10.1016/s1063-4584(05)80013-5.
9
Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee.透明质酸钠凝胶(hylan G-F 20)关节腔注射治疗膝骨关节炎的26周疗效与安全性对照试验
Clin Ther. 1998 May-Jun;20(3):410-23. doi: 10.1016/s0149-2918(98)80052-0.
10
Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?是否有证据支持在髋骨关节炎患者的治疗模式中纳入关节腔注射透明质酸治疗?
Clin Exp Rheumatol. 2005 Sep-Oct;23(5):711-6.

引用本文的文献

1
Therapeutic potential of hyaluronic acid hydrogel combined with bone marrow stem cells-conditioned medium on arthritic rats' TMJs.透明质酸水凝胶联合骨髓间充质干细胞条件培养液对关节炎大鼠颞下颌关节的治疗潜力。
Sci Rep. 2024 Nov 5;14(1):26828. doi: 10.1038/s41598-024-77325-6.
2
Effectiveness of a Single Intra-articular Injection of High-Molecular-Weight Hyaluronic Acid Versus NSAIDs on the Visual Analog Pain Scale and Western Ontario and McMaster Universities Osteoarthritis Index Scores in Patients With Knee Osteoarthritis.单关节腔内注射高分子量透明质酸与非甾体抗炎药对膝关节骨关节炎患者视觉模拟疼痛量表及西安大略和麦克马斯特大学骨关节炎指数评分的有效性比较
Cureus. 2024 Sep 13;16(9):e69313. doi: 10.7759/cureus.69313. eCollection 2024 Sep.
3
Collagen type II solution extracted from supercritical carbon dioxide decellularized porcine cartilage: regenerative efficacy on post-traumatic osteoarthritis model.超临界二氧化碳脱细胞猪软骨提取的II型胶原溶液:对创伤后骨关节炎模型的再生疗效
Bioresour Bioprocess. 2024 Feb 3;11(1):21. doi: 10.1186/s40643-024-00731-1.
4
Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial.对于慢性特发性膝骨关节炎患者,与安慰剂相比,每周一次、共三次关节腔内注射透明质酸钠凝胶20能显著改善疼痛缓解情况:一项单中心、评估者盲法和患者盲法的随机对照试验。
Drugs Context. 2024 Apr 5;13. doi: 10.7573/dic.2023-11-3. eCollection 2024.
5
Evaluation of single and multiple hyaluronic acid injections at different concentrations with high molecular weight in the treatment of knee osteoarthritis.评价不同浓度、高分子量的单剂量和多剂量透明质酸注射治疗膝骨关节炎的效果。
BMC Musculoskelet Disord. 2024 Feb 21;25(1):164. doi: 10.1186/s12891-024-07200-y.
6
The novel hyaluronic acid granular hydrogel attenuates osteoarthritis progression by inhibiting the TLR-2/NF-κB signaling pathway through suppressing cellular senescence.新型透明质酸颗粒水凝胶通过抑制细胞衰老来抑制TLR-2/NF-κB信号通路,从而减缓骨关节炎的进展。
Bioeng Transl Med. 2022 Dec 23;8(3):e10475. doi: 10.1002/btm2.10475. eCollection 2023 May.
7
Intra-articular Injections of Cross-linked Hyaluronic Acid in Japanese Patients with Symptomatic Osteoarthritis of the Hip.交联透明质酸关节腔内注射治疗日本有症状的髋关节骨关节炎患者
Prog Rehabil Med. 2021 Sep 29;6:20210038. doi: 10.2490/prm.20210038. eCollection 2021.
8
Molecular and Cellular Effects of Chemical Chaperone-TUDCA on ER-Stressed NHAC-kn Human Articular Chondrocytes Cultured in Normoxic and Hypoxic Conditions.化学伴侣 TUDCA 对常氧和低氧条件下培养的 NHAC-kn 人关节软骨细胞内质网应激的分子和细胞作用。
Molecules. 2021 Feb 7;26(4):878. doi: 10.3390/molecules26040878.
9
Single- and double-dose of platelet-rich plasma hyaluronic acid for treatment of knee osteoarthritis: A randomized controlled trial.单剂量和双剂量富血小板血浆联合透明质酸治疗膝骨关节炎:一项随机对照试验。
World J Orthop. 2019 Sep 18;10(9):310-326. doi: 10.5312/wjo.v10.i9.310.
10
A placebo-controlled study comparing the efficacy of intra-articular injections of hyaluronic acid and a novel hyaluronic acid-platelet-rich plasma conjugate in a canine model of osteoarthritis.一项安慰剂对照研究比较了关节内注射透明质酸和新型透明质酸-富血小板血浆缀合物在犬骨关节炎模型中的疗效。
J Orthop Surg Res. 2019 Sep 18;14(1):314. doi: 10.1186/s13018-019-1352-1.

本文引用的文献

1
Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff. Open-label prospective multicenter study.Hylan G-F 20 在肩袖完整的肩关节骨关节炎中的疗效和安全性。开放性前瞻性多中心研究。
Joint Bone Spine. 2009 Dec;76(6):670-3. doi: 10.1016/j.jbspin.2009.10.008.
2
Injectable hyaluronan for the treatment of carpometacarpal osteoarthritis: open label pilot trial.注射用透明质酸治疗掌指关节骨关节炎:开放标签试点试验。
Curr Med Res Opin. 2009 Sep;25(9):2103-8. doi: 10.1185/03007990903084016.
3
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.单次关节内注射 6ml 海乐® G-F 20 治疗膝关节症状性原发性骨关节炎患者:一项随机、多中心、双盲、安慰剂对照试验。
Ann Rheum Dis. 2010 Jan;69(1):113-9. doi: 10.1136/ard.2008.094623.
4
The evaluation of efficacy and tolerability of Hylan G-F 20 in bilateral thumb base osteoarthritis: 6 months follow-up.
Clin Rheumatol. 2009 May;28(5):535-41. doi: 10.1007/s10067-008-1080-0. Epub 2009 Jan 10.
5
A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) osteoarthritis.一项关于透明质酸钠凝胶G-F 20(施沛特)治疗有症状的踝关节(距小腿关节)骨关节炎患者安全性和有效性的前瞻性多中心开放性研究。
Foot Ankle Surg. 2008;14(3):145-52. doi: 10.1016/j.fas.2008.01.001. Epub 2008 Mar 4.
6
Viscosupplementation for grade II osteoarthritis of the ankle: a prospective study at 18 months' follow-up.踝关节II级骨关节炎的粘弹性补充治疗:一项随访18个月的前瞻性研究。
Chir Organi Mov. 2008 Dec;92(3):155-60. doi: 10.1007/s12306-008-0066-z. Epub 2008 Dec 6.
7
The role of viscosupplementation in the ankle using hylan G-F 20.使用透明质酸钠凝胶(hylan G-F 20)进行踝关节粘弹性补充疗法的作用。
J Foot Ankle Surg. 2008 Sep-Oct;47(5):377-84. doi: 10.1053/j.jfas.2008.06.013.
8
Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.交联透明质酸钠凝胶和透明质酸钠治疗膝骨关节炎的疗效——一项前瞻性随机临床试验
Knee. 2008 Aug;15(4):318-24. doi: 10.1016/j.knee.2008.02.012. Epub 2008 Apr 21.
9
Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice.在有症状的髋关节骨关节炎患者中关节腔内注射透明质酸钠凝胶G-F 20:一项临床实践中大型队列研究的耐受性和有效性
Curr Med Res Opin. 2008 May;24(5):1309-16. doi: 10.1185/030079908x291930. Epub 2008 Mar 27.
10
Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.前瞻性、多中心、随机评估透明质酸钠凝胶G-F 20五种给药方案对症状性胫股关节骨关节炎患者进行粘弹性补充治疗的安全性和有效性:一项试点研究。
Arch Orthop Trauma Surg. 2009 Mar;129(3):417-23. doi: 10.1007/s00402-008-0601-2. Epub 2008 Mar 26.